Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Teva Pharmaceutical Industries Limited is 'Cautious Hold'. Macroaxis provides Teva Pharmaceutical buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TEVA positions. The advice algorithm takes into account all of Teva Pharmaceutical available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from TEVA buy-and-hold prospective. Also please take a look at Teva Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon Teva Pharmaceutical Industries Limited has a mean deviation of 2.03, semi deviation of 0.0, standard deviation of 3.11, variance of 9.69, downside variance of 0.0 and semi variance of 0.0Macroaxis provides recommendation on Teva Pharmaceutical to complement and cross-verify current analyst consensus on Teva Pharmaceutical Industries Limited. Our buy or sell recommendation engine determines the firm potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Teva Pharmaceutical is not overpriced, please validate all Teva Pharmaceutical fundamentals including its Cash and Equivalents, Total Debt and the relationship between Net Income and Cash per Share .
Teva Pharmaceutical Trading Alerts and Improvement Suggestions
Teva Pharmaceutical generates negative expected return over the last 30 days
Teva Pharmaceutical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 29.16B in total debt with debt to equity ratio (D/E) of 184.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Teva Pharmaceutical has Current Ratio of 0.94 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported revenue of 18.08B. Net Loss for the year was (3.56B) with profit before overhead, payroll, taxes, and interest of 8.3B.
Teva Pharmaceutical Industries Limited exhibits very low volatility with skewness of -1.96 and kurtosis of 6.1. However, we advise investors to further study Teva Pharmaceutical Industries Limited technical indicators to make sure all market info is available and is reliable.